Menta Capital’s Merck MRK Stock Holding History

Menta Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17,659	Closed	-$992K	–	920
2016 Q4	$992K	Buy	17,659 +4,087	+30%	+$239K	0.08%	430
2016 Q3	$808K	Buy	+13,572	New	+$794K	0.08%	432

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Menta Capital's MRK Position: Q1 2017 in Review

Menta Capital sold out of Merck (MRK) in Q1 2017, closing a stake of 17,659 shares — an estimated $992K sold.

Menta Capital first reported a position in MRK in Q3 2016 and held it in 2 quarters. The position peaked at $992K in Q4 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

Menta Capital reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
Menta Capital sold 17,659 Merck shares in Q1 2017, an estimated $992K.
Menta Capital first reported a position in Merck in Q3 2016 and held it in 2 quarters.
Menta Capital's Merck position peaked at $992K in Q4 2016.
1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Menta Capital's 13F filing for Q1 2017, filed 12 May 2017.